Calicheamicin
WikiDoc Resources for Calicheamicin |
Articles |
---|
Most recent articles on Calicheamicin Most cited articles on Calicheamicin |
Media |
Powerpoint slides on Calicheamicin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Calicheamicin at Clinical Trials.gov Trial results on Calicheamicin Clinical Trials on Calicheamicin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Calicheamicin NICE Guidance on Calicheamicin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Calicheamicin Discussion groups on Calicheamicin Patient Handouts on Calicheamicin Directions to Hospitals Treating Calicheamicin Risk calculators and risk factors for Calicheamicin
|
Healthcare Provider Resources |
Causes & Risk Factors for Calicheamicin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Calicheamicin is an antibiotic derived from organism Micromonospora echinospora. It was isolated originally from a rock collected in Waco, Texas by a hiking Scripps Institute chemist.
It is highly toxic but has found pharmacological use as a conjugate in antibody cancer therapeutics (e.g. Gemtuzumab).
References
- http://www.scripps.edu/newsandviews/e_20010226/nicolaou3.html
- J Antibiot (Tokyo). 1989 Jul;42(7):1070-87.